Abstract
Objective(s)
To evaluate the efficacy of single dose nevirapine in the prevention of mother to child transmission of HIV-1 in 30 HIV-1 infected parturients.
Material and Method(s)
This study was necessary since any study has not been conducted in an Indian population, were usually women are not offered antiretroviral therapy during pregnancy but only peripartum. East Go-davari District of Andhra Pradesh, India, has the highest prevalence (2.5%) of HTV-1 positive antenatal women, according to NACO estimations. Therefore, the study was conducted in Lutheran General Hospital, Rajahmundry, East Godavari District, Andhra Pradesh, India, at a 50-bedded hospital offering health care to people living with HIV/AIDS. One year prospective study with 30 Primigravidae infected with HTV-1, were planned for elective cesarean section. Single dose 200mg tablet was administered two hours prior to the cesarean section and all babies were given nevirapine syrup 2mg/kg within 72 hours of birth. Babies were tested for HIV-1 at one and two weeks of birth.
Result(s)
All the women were primigravidae. Nineteen babies born to these mothers tested positive for HTV-1 after two weeks, confirming the transmission rate to be 63.33% (95% CI of proportion 45.36%–78.15%). Thus, the efficacy of single dose nevirapine in preventing mother to child transmission was found to be 36.67%. Neonatal morbidity was more in those babies that were HTV positive. Two neonatal deaths occurred in two weeks and both babies were HTV-1 positive.
Conclusion(s)
Single dose nevirapine is associated with a lower efficacy in preventing mother to child transmission of HTV-1.
Keywords: HTV, mother to child transmission, prevention, single dose nevirapne
Full Text
The Full Text of this article is available as a PDF (2.7 MB).
References
- 1.Rogers A., Meundi A., Arnim A., et al. HIV-related knowledge, attitudes, perceived benefits and risks of HIV testing among pregnant women in rural Southern India. AIDS Patient Care STDS. 2006;20:803–811. doi: 10.1089/apc.2006.20.803. [DOI] [PubMed] [Google Scholar]
- 2.Chersich M.F., Gray G.E. Progress and emerging challenges in prevention of mother to child transmission. Curr Infect Dis Rep. 2005;7:393–400. doi: 10.1007/s11908-005-0014-0. [DOI] [PubMed] [Google Scholar]
- 3.Damania K.R., Tank P.D. Prevention of mother to child transmission of HIV infection. J Obstet Gynecol India. 2006;56:390–395. [Google Scholar]
- 4.Guay L.A., Musoke P., Flemming T., et al. Intrapartum and neonatal single dose nevirapine compared to zidovudine for prevention of mother-to-child transmission of HIV-1, Kampala, Uganda: HIVNET 012 Randomized trail. Lancet. 1999;354:795–802. doi: 10.1016/S0140-6736(99)80008-7. [DOI] [PubMed] [Google Scholar]
- 5.Mclntyre J. Strategies to prevent mother-to-child transmission of HIV. Current Opin Infect Dis. 2006;19:33–38. doi: 10.1097/01.qco.0000200290.99790.72. [DOI] [PubMed] [Google Scholar]
- 6.Plipat T., Naiwatanakul T., Rattanasuporn N., et al. Reduction in mother-to-child transmission of HIV in Thailand, 2001–2003: results from population based surveillance in six provinces. AIDS. 2007;21:145–151. doi: 10.1097/QAD.0b013e328010e02d. [DOI] [PubMed] [Google Scholar]
- 7.Johnson N., Mullings A.A., Harvey K.M., et al. HIV Seroprevalence, uptake of interventions to reduce mother-to-child transmission and birth outcomes in Greater Kingston, Jamaica. West Indian Med J. 2004;53:297–302. [PubMed] [Google Scholar]
- 8.Ekouevi D.K., Tonwe-Gold B., Davis F. Advances in the prevention of mother-to-child transmission of HIV-1 infection in resource-limited settings. AIDS Read. 2005;15:479–480. [PubMed] [Google Scholar]
- 9.World Heath Organization. Antiretroviral drugs and the prevention of mother-to-child transmission of HTV infection in resource limited settings. Recommendations for a public health approach (2005 revision). http://www.who.int/3by5/PMTCTreport_June2005.pdf. (Accessed in April 2010)